MedPath
FDA Approval

Colesevelam hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Tris Pharma Inc
DUNS: 947472119
Effective Date
June 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Colesevelam(625 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Colesevelam hydrochloride

Product Details

NDC Product Code
27808-190
Application Number
ANDA209946
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 30, 2022
Code: P4SG24WI5QClass: ACTIBQuantity: 625 mg in 1 1
AMMONIAInactive
Code: 5138Q19F1XClass: IACT
BUTYL ALCOHOLInactive
Code: 8PJ61P6TS3Class: IACT
DIACETYLATED MONOGLYCERIDESInactive
Code: 5Z17386USFClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
ISOPROPYL ALCOHOLInactive
Code: ND2M416302Class: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
HYPROMELLOSE 2910 (15 MPA.S)Inactive
Code: 36SFW2JZ0WClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
SHELLACInactive
Code: 46N107B71OClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath